Ardent Health Partners, LLC (ARDT) Revenue History
Annual and quarterly revenue from 2016 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ARDT Revenue Growth
Revenue Breakdown (FY 2025)
ARDT's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ARDT Revenue Analysis (2016–2025)
As of May 8, 2026, Ardent Health Partners, LLC (ARDT) generated trailing twelve-month (TTM) revenue of $6.43 billion, reflecting solid growth of +7.0% year-over-year. The most recent quarter (Q1 2026) recorded $1.60 billion in revenue, down 0.2% sequentially.
Looking at the longer-term picture, ARDT's historical revenue data shows a 3-year CAGR of +7.2%. The company achieved its highest annual revenue of $6.32 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows ARDT's business is primarily driven by Reportable Segment (100%). With over half of revenue concentrated in Reportable Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including HCA (+7.1% YoY), THC (+4.6% YoY), and CYH (+69.8% YoY), ARDT has underperformed the peer group in terms of revenue growth. Compare ARDT vs HCA →
ARDT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ARDTCurrent | $6.4B | +7.0% | - | 5.1% | |
 HCA | $75.6B | +7.1% | +8.0% | 15.8% | |
 THC | $21.3B | +4.6% | +3.9% | 16.1% | |
 CYH | $12.5B | +69.8% | +1.2% | -79.4% | |
 UHS | $17.4B | +10.4% | +8.5% | 11.5% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% |
ARDT Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.32B | +6.0% | $6.17B | 97.5% | $325.6M | 5.1% |
| 2024 | $5.97B | +10.3% | $4.93B | 82.7% | $405.8M | 6.8% |
| 2023 | $5.41B | +5.5% | $5.27B | 97.4% | $229.5M | 4.2% |
| 2022 | $5.13B | +23.3% | $4.17B | 81.4% | $217.0M | 4.2% |
| 2018 | $4.16B | +38.6% | $4.16B | 100.0% | $149.8M | 3.6% |
| 2017 | $3.00B | +42.6% | $3.00B | 100.0% | $121.8M | 4.1% |
| 2016 | $2.11B | - | $2.11B | 100.0% | $84.8M | 4.0% |
See ARDT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARDT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ARDT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonARDT — Frequently Asked Questions
Quick answers to the most common questions about buying ARDT stock.
Is ARDT's revenue growth accelerating or slowing?
ARDT maintains +7.0% revenue growth, in line with its 5-year CAGR of N/A. TTM revenue stands at $6.4B. Growth rate remains consistent with historical average.
What is ARDT's long-term revenue growth rate?
Ardent Health Partners, LLC's 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +7.0% is near this long-term average.
How is ARDT's revenue distributed by segment?
ARDT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2025 are available for download. Segment mix reveals concentration and diversification trends.